← Open Payments lookup

JAMIE LUMMUS: Open Payments

NPI 1417401415 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,894 in 62 payments from 29 companies in 2025. Trend: 2023 $224 · 2024 $1,329 · 2025 $1,894

Food & beverage: $1,894
CompanyPaymentsAmount
GENZYME CORPORATION2$289
PFIZER INC.8$170
ABBVIE INC.7$167
AstraZeneca Pharmaceuticals LP5$157
Janssen Biotech, Inc.3$137
Regeneron Healthcare Solutions, Inc.1$135
Takeda Pharmaceuticals U.S.A., Inc.3$98
Genentech USA, Inc.4$93
Novartis Pharmaceuticals Corporation4$79
Secura Bio, Inc.2$57

Products named: SARCLISA, LYNOZYFIC, IMFINZI, RYBREVANT, IBRANCE, EPKINLY, ICLUSIG, IMBRUVICA.

Industry payments across WA — which companies pay providers there.